Business
PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call
PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, April 29, 2020\n\n\n\nTORONTO, April 29, 2020 /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV:PCLO, OTCQX:PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., advised today that it will be holding its fourth quarter and fiscal 2019 financial results conference call on April 30, 2020 at 9:00 a.m. ET. While the Company's usual year-end audit process was delayed as a result of the ongoing COVID-19 pandemic, the Company will be filing its financial results tonight, April 29, 2020, consistent with the regulatory schedule.\n\n \n \n \n \n \n \n\n \nCONFERENCE CALL \nPharmaCielo will host a conference call on Thursday, April 30th, 2020, at 9:00 a.m. ET to discuss its financial results and provide investors with key business highlights. The call will be chaired by David Attard, CEO, David Gordon, CCO and Scott Laitinen, CFO.\nCONFERENCE CALL DETAILS\nDate: April 30th, 2020 | Time: 9:00 a.m. ET\nParticipant Dial-in: 416-764-8650 or 1-888-664-6383\nReplay Dial-in: 416-764-8677 or 1-888-390-0541\n(Available for 2 weeks – Expiring May 14th, 2020) \nConference ID: 58230664 \nPlayback #: 230664 \nListen to webcast: pcloevent.on24.com\nAbout PharmaCielo\nPharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia.\n\n\n\nSOURCE PharmaCielo Ltd.\n\n\n\n View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2020/29/c6279.html\n\n\n\n...